@article{264a38eb4a3f4bc6b8f877d7dfb1ad95,
title = "Disease-modifying anti-rheumatic drugs (DMARDs) for Sjogren{\textquoteright}s syndrome",
abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of DMARDs in the treatment of Sj{\"o}gren{\textquoteright}s syndrome.",
author = "Roberta Gualtierotti and Matteo Rota and Lopez-Olivo, {Maria Angeles} and Francesco Spadari and {La Vecchia}, Carlo and Massimo Cugno",
note = "Funding Information: RG: RG is the recipient of a joint grant by Cariplo and Fondazione Regionale per la Ricerca Biomedica (n. 2017–1938). This work was partially supported by the Italian Ministry of Health-Bando Ricerca Corrente. Funding Information: RG is the recipient of a joint grant by Cariplo and Fondazione Regionale per la Ricerca Biomedica. Funding Information: MA L-O: MA L-O was the recipient of a career award from the Rheumatology Research Foundation. She also received funding from Complete Health Economics Outcomes Research Solutions (CHEORS) and payment from Elsevier for review preparation. Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",
year = "2021",
month = may,
day = "10",
doi = "10.1002/14651858.CD014529",
language = "English (US)",
volume = "2021",
journal = "Cochrane Database of Systematic Reviews",
issn = "1465-1858",
publisher = "John Wiley and Sons Ltd",
number = "5",
}